Genentech wins FDA OK for at-home combo of 2 marquee cancer drugs

Genentech did not disclose a price for the drug, a new combination of its legendary drugs Herceptin and Perjeta using time-saving injection just below the skin.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.